Vontobel Holding
IONS icon

Vontobel Holding’s Ionis Pharmaceuticals IONS Stock Holding History

Vontobel Holding’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
4,957
-283
-5% -$21.3K ﹤0.01% 1139
2026
Q1 		$393K Hold
5,240
– – ﹤0.01% 921
2025
Q4 		$415K Buy
+5,240
New +$395K ﹤0.01% 1052
2025
Q1 		– Sell
-5,865
Closed -$205K – 1123
2024
Q4 		$205K Buy
5,865
+363
+7% +$13.6K ﹤0.01% 1011
2024
Q3 		$220K Sell
5,502
-2,483
-31% -$116K ﹤0.01% 992
2024
Q2 		$381K Buy
7,985
+488
+7% +$20K ﹤0.01% 846
2024
Q1 		$325K Sell
7,497
-713
-9% -$34K ﹤0.01% 887
2023
Q4 		$415K Sell
8,210
-6
-0.1% -$287 ﹤0.01% 845
2023
Q3 		$373K Sell
8,216
-350
-4% -$14.4K ﹤0.01% 843
2023
Q2 		$351K Sell
8,566
-1,250
-13% -$48K ﹤0.01% 886
2023
Q1 		$351K Sell
9,816
-1,113
-10% -$41.8K ﹤0.01% 854
2022
Q4 		$406K Sell
10,929
-353
-3% -$14.8K ﹤0.01% 811
2022
Q3 		$499K Sell
11,282
-2,928
-21% -$123K 0.01% 716
2022
Q2 		$534K Sell
14,210
-505
-3% -$19K 0.01% 700
2022
Q1 		$545K Buy
14,715
+3,405
+30% +$111K ﹤0.01% 768
2021
Q4 		$344K Buy
+11,310
New +$356K ﹤0.01% 898

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vontobel Holding's IONS Position: Q2 2026 in Review

Vontobel Holding reduced its Ionis Pharmaceuticals (IONS) stake by 5.4% in Q2 2026, selling an estimated $21.3K and leaving 4,957 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Vontobel Holding first reported a position in IONS in Q4 2021 and has held it in 16 quarters since. The position peaked at $545K in Q1 2022. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Vontobel Holding held 4,957 shares of Ionis Pharmaceuticals worth $393K as of Q2 2026.
  • Vontobel Holding sold 283 Ionis Pharmaceuticals shares in Q2 2026, an estimated $21.3K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1139 holding.
  • Vontobel Holding first reported a position in Ionis Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • Vontobel Holding's Ionis Pharmaceuticals position peaked at $545K in Q1 2022.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.